Lv65
2650 积分 2021-03-07 加入
“Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability”
17天前
已完结
Potential of Liposomes for Enhancement of Oral Drug Absorption
17天前
已完结
Antibody Approaches To Treat Brain Diseases
1个月前
已完结
Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies
1个月前
已完结
Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial
1个月前
已完结
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
1个月前
已完结
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
1个月前
已完结
Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1
1个月前
已完结
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
1个月前
已完结
Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
1个月前
已完结
皖公网安备34019202002308
